UPMC Enterprises, the innovation, commercialization and venture capital arm of the health system, has finalized an agreement for eVisit to purchase its inpatient teleconsult technology platform. This technology, developed by UPMC in 2020, enables virtual clinical specialists to collaborate with bedside clinicians on inpatient care.
The platform supports consultations in areas such as stroke, neurology, critical care, psychology and toxicology. This acquisition will enhance eVisit’s inpatient telehealth capabilities, according to a June 25 news release from the software vendor.
In addition to providing technology advisory expertise to eVisit, UPMC Enterprises and Columbia, Md.-based MedStar Health separately contributed to eVisit’s $45 million Series B fundraising. Both organizations will partner with eVisit on new projects and have representatives serving on eVisit’s clinical advisory board.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
